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Introduction 
The last two decades have seen a rapid development of a variety of new 
techniques and probes to understand the regulatory functions of hormones. 
One such tool is antibodies against hormones. Antibodies against he gonado- 
tropins Lutropin (LH) and Follitropin (FSH), in addition to showing 
hormonal specificity, react with LH and FSH of a variety of other species 
(1-3). This property has been found extremely useful in developing hetero- 
logous radioimmunoassay (RIA) systems (4) and also for neutralizing 
endogenous LH or FSH at critical periods of reproduction i  a variety of 
animals (5, 6). 
The classical approach to study the action of gonadotropins has been to 
use the hypophysectomized animal model and administer as required hor- 
mones having LH or FSH activity. Such an approach would result in the 
removal, at a stroke, of all the pituitary hormones other than the supple- 
mented gonadotropin. In this procedure the permissive or antagonistic effect 
that the other pituitary hormones may have on the gonadotropin action 
when animals are in a normal physiological state is mostly overlooked. In 
contrast, use of an antibody, whose specificity can readily be manipulated, 
ensures that a physiologically normal animal can be deprived of a single 
hormone at any given time for a fixed period. This approach as been taken 
advantage of in elucidating, beyond reasonable doubt, the luteotropic 
activity o fLH in the cycling and pregnant rat, hamster, ~nonkey and the 
rabbit (7,8). Use of a specific FSH antibody similarly helped to establish, for 
the first time, the need for this hormone in maintaining spermatogenesis and 
fertility in the primate (9-12). Further, specific gonadotropin antibodies 
have also been employed successfully in studying events like follicular 
maturation, ovulation, implantation and also as a vaccine to prevent or 
terminate pregnancy. This aspect has been reviewed in depth earlier (7, 13,14). 
In the present paper emphasis will be laid on discussing in some depth how 
specific LH and FSH antibodies have been used to further our knowledge of 
the mechanism of action of these hormones at the cellular level. 
Characterization f Antibodies 
The use of gonadotropin antibodies as specific hormone antagonists 
necessitated the development of methods to characterize these antibodies for 
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specificity. Even though the LH or FSH used as immunogen in earlier years 
was relatively pure, it was not possible to obtain antisera free of contaminat- 
ing antibodies against he other pituitary proteins. This was particularly true 
of FSH antisera, which used to be contaminated to a large extent with 
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Fig. 1. Characterization of hCG-alpha and -beta antiserum (a/s). 
Different dilutions of crude and processed (passed twice through 
Sepharose to which the counter subunit is attached), hCG-alpha or 
-beta antisera (100/11 of each dilution) were incubated with 12SI-hCG, 
12SI-hCG-alpha, or 12SI-hCG-beta for 12 h at 37~ The antigen-antibody 
complex was precipitated by adding 100#1 each of 1/50 diluted NRS 
and goat antibody to rabbit gamma globulin and continuing incubation 
for 12 more hours. Binding was determined as described in (19). 
Results have been expressed as bound c.p.m./total c.p.m, x 100 versus 
reciprocal of antiserum dilution. 
(a) hCG-alpha antisera. 
D, 12SI-hCG -I- crude antiserum. 
I ,  12SI-hCG + processed antiserum. 
o, 12SI-hCG-beta + crude antiserum. 
e, 12SI-hCG-beta + processed antiserum. 
(b) hCG-beta antisera. 
o, 12SI-hCG + crude antiserum. 
e, 12SI-hCG + processed antiserum. 
A, 12SI-hCG-alpha + crude antiserum. 
A, 12SI-hCG-alpha + processed antiserum. 
(After Dighe & Moudgal [ 19 ]). 
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antibodies to LH and other non-specific proteins. The contaminating anti- 
bodies had to be removed by manual addition of the contaminants in
repeated small quantities (6). With the advent of immunoaffinity procedures, 
this is totally obviated (15). Such procedures have been used to cleanse FSH 
antiserum of LH antibody contamination (10), and FSH, before being used 
as an immunogen, of LH contamination by passing FSH through an LH 
antibody coupled CNBr or epoxyactivated Sepharose column (16). 
The cross-reactivity of FSH antibodies with LH can also be ascribed to 
sharing of common alpha subunit between LH, FSH and TSH of any given 
species. However, because the alpha-subunit s a poor immunogen, unless 
deliberate attempts are made to produce antibodies to it, over 90% of the 
antibodies produced to intact undissociated hormone are directed towards 
the beta subunit [for example, oLH (17, 18)]; that is, the antibodies are 
conformation-specific. Antisera raised to individual alpha and beta subunits 
of human Chorionic Gonadotropin (hCG) have been made specific by treat- 
ing the individual antisera with the counter subunit coupled to immuno- 
affinity matrix (19). Such characterized antisera still react with the native 
undissociated hormone (Fig. 1). Attempts have been made to predict, on 
the basis of hydrophilicity, the number of potential antigenic determinants 
hCG or hLH may possess (20). Monoclonal antibodies to hCG have also been 
produced (21), and the use of these in mapping the receptor binding domain(s) 
of the hormone will be commented upon later. FSH provides mostly confor- 
mation-specific antibodies (22), the cross-reactivity with the free beta 
subunit being minimal (23). Further, immunization with FSH, unlike LH or 
hCG, results in antibodies which form only a soluble complex (24). 
The gonadotropin antisera thus far used for neutralization of hormonal 
activity have been polyclonal in nature and have been produced in a variety 
of animals which include rabbits, monkeys and horses. While most gonado- 
tropic antisera are capable of neutralizing the hormonal activity, some 
investigators have observed an accentuation of the hormonal response with 
the addition of antibodies (25). Due to incomplete information on the 
characterization f such antibodies it is difficult to pinpoint he reasons for 
such observation. 
Use of Antisera in Studying the Dependency of Gonadal Steroidogenesis on
LH and/or FSH 
The gonads of both the male and the female of a variety of species (e.g. 
rat, mouse, hamster, rabbit and monkey) are very sensitive to deprivation of 
LH support. For instance, it has been shown in the case of the female 
pregnant hamster (Fig. 2) and the cycling monkey (Fig. 3) that within a few 
hours of antiserum injection, the steroid output from the luteal compart- 
ment of the ovary drops significantly: the effect of this is termination of 
either pregnancy or cycle (29,54). The resilience of the luteal tissue has 
been shown by using an antiserum of low titer. In such a case the reduction 
in progestin output is transient, the luteal tissue returning to normalcy once 
the antibody activity is spent (26). For the luteal tissue of the monkey to 
become totally insensitive to LH action, it is necessary to deprive the animal 
of LH support for at least 48 h. LH has also been shown to stimulate ctioles- 
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Fig. 2. Composite diagram represent- 
ing the effect of LH antiserum on pro- 
gesterone (P) and estrogen (E) levels in 
serum (A, ng/ml), in corpus luteum (o) 
and in the non-luteal compartment (o) 
of the ovary of the pregnant hamster. 
Solid lines represent P (ng/mg) while 
broken lines represent E (pg/mg) levels. 
(After Mukku & Moudgal [29]). 
terol ester hydrolysis (27). In keeping with this is the observation that 
following LH deprivation the cholesterol ester levels of the luteal tissue rise 
rapidly (28, 29), this effect being much more marked than is altered pro- 
gesterone production. Interestingly, even when the luteal tissue is seemingly 
insensitive to LH deprivation in terms of progesterone synthesis, its basic 
dependence on LH is demonstrable if cholesterol ester levels are monitored 
(52). This is best illustrated by studying the effect that LH deprivation 
produces in the luteal tissue of rats on different days of pregnancy (Table 1). 
In contrast o these observations, the rat corpora lutea desensitized by treat- 
ment with a high dose of  hCG show some decrease in the  total cholesterol 
level without any change in the free/esterified cholesterol ratio (Table 2). 
The progesterone production in desensitized corpora lutea could be stimu- 
lated by the addition of cholesterol (30), while the luteolytic corpora lutea 
are unable to do so in spite of higher cholesterol levels. It appears from these 
studies that the biochemical events responsible for inhibition of steroido- 
genesis of corpora lutea deprived of LH are different from that of corpora 
lutea made deficient in the LH receptors. Within 1 h of  injection of LH 
antibodies into the mate rodent or monkey, testosterone production is 
drastically reduced, thus showing that even the male gonadal steroidogenesis 
is dependent upon continuous LH support (31). The specificity of the anti- 
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Fig. 3. Effect of injection of a chimpanzee antiserum to oLH beta 
subunit on serum progesterone l vels of cycling bonnet monkeys. 5 ml 
of antiserum was injected i.v. on day 18 of cycle, and blood samples 
collected at times thereafter were analysed for progesterone. Controls 
received an equivalent volume of normal chimpanzee serum, n of 
controls = 2; exptl = 3. (After Moudgal et al. [54]). The other three 
curves represent decrease in serum progesterone after antiserum treat- 
ment of three individual monkeys, nos. 80 (zx), 48 (o) and 508 (D). 
Table 1. Effect of LH deprivation on the corpus luteum levels of progesterone and 
cholesterol on different days of pregnancy in the rat 
0.3 ml of LH antiserum was injected into experimental nimals, and the animals were 
autopsied 24 h later. Controls received an equal volume of normal rabbit serum. The free 
and esterified sterol levels were measured by appropriate methods described elsewhere. 
Results based on Mukku and Moudgal (52). n of each group = 4; values are means + S.D. 
Treatment Progesterone Free cholesterol Esterified cholesterol 
on days (ng/mg) (/2g/mg) (/2g/mg) 
of 
pregnancy Control Antiserum Control Antiserum Control Antiserum 
6 83.7+14.3 102.2+10.0 1.2-+0.0 2.2+0.3 1.3.+0.4 17.5.+3.4 
7 110.8.+22.6 32.6-+1.9 1.5-+0.0 2.2-+0.2 1.6-+0.3 15.6-+1.8 
8 79.3+7.6 6.3+1.1 1.2+0.1 2.5+0.3 1.4+0.1 13.4+1.9 
body  effect  is apparent  f rom the fact that  ne i ther  normal  serum nor  FSH 
ant i serum had an  effect  on  the LH-speci f ic  luteal  or Leydig cell funct ion .  
Ant ibod ies  to FSH have been used in s tudy ing  the specif ic role of  FSH in 
(a) ovar ian granu losa  cell mu l t ip l i ca t ion  (32,  5 6), (b) regulat ing the aromat iz -  
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Table 2. Endogenous free and esterified cholesterol in control and desensitized corpora 
lutea 
Immature female rats made pseudopregnant bysequential treatment with PMSG and an 
ovulatory dose of hCG were treated with a desensitizing dose (4//g) of hCG 4 days 
following the ovulatory trigger. Rats were killed at 0, 12 and 24 h after hCG injection, 
corpora lutea isolated from individual rats and free and esterified cholesterol measured 
according to the procedure outlined earlier (29). Values are means + S.D. of 4 animals per 
group. 
h after hCG Cholesterol Esterified cholesterol Cholesterol* total 
treatment (pg/mg tissue) cholesterol equivalent (pg/mg tissue) 
(//g/mg tissue) 
0 0.99 + 0.13 2.36 + 0.24 3.37 +- 0.37 
12 0.63 + 0.12 1.54 -+ 0.36 2.46 + 0.45 
24 0.73 + 0.14 1.88 + 0.29 2.61 + 0.40 
* Value obtained by adding free cholesterol and esterified cholesterol. 
ing ability of the granulosa cells (53) and (c) regulation of LH receptors 
(33). In vitro studies with the non-luteal portion of ovaries from the FSH 
antiserum treated hamster with and without FSH have shown that aromatiza- 
tion of androgens to estrogen is an FSH-dependent phenomenon (53). The 
dependence of the follicular apparatus on FSH seems to vary depending on 
the species and can be determined with FSH antiserum. While in the cycling 
hamster follicular maturation is dependent upon FSH up to diestrous even- 
ing (32), in the monkey the growing follicle appears to become independent 
after day 8 of  the cycle (34). Interestingly in the rabbit, which is an induced 
ovulator, the ovulatory action of LH can be blocked by giving FSH anti- 
serum 6 h prior to the ovulatory trigger (35). Follicular atresia, a lytic 
process signalling termination of follicular development of a majority of 
follicles, can be brought about by injection of FSH antiserum. In the rat it 
has been observed that a lack of FSH leads to inhibition of estrogen produc- 
tion and this in turn brings about an increase in lysosomal enzymes respon- 
sible for cell lysis (36). 
Use of Antibodies in Studying Gonadotropin-Receptor Interaction 
Currently the binding of 12sI labelled gonadotropin to the membrane 
component of  the cell is used as a measure of receptor binding. The first 
demonstration that physiologically active LH can bind to receptors was that 
of Moudgal et al. (37), using a mouse Leydig tumor cell system and a modi- 
fied RIA capable of measuring tissue bound hormone. They showed that the 
Leydig cells bind LH in a dose-dependent manner and that this can be corre- 
lated to testosterone production. A similar observation has been made with 
respect o FSH binding to rat ovarian granulosa cells and estrogen production 
(44). A direct correlation between FSH bound to the receptor and estrogen 
produced is evident from Fig. 4. The modification in, the RIA essentially 
consisted of incubating tissue homogenates at 37 ~ instead of 4 ~ Incubation 
at 37 ~ for 12 h tends to inactivate the receptor, with the result that the 
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Fig. 4. Establishment of correlation between binding of FSH to rat 
granulosa cells and accompanying response. FSH and estradiol were 
measured using appropriate RIA. Inset provides a plot of the FSH 
bound to the ceils against he estradiot produced. Regression analysis of 
the data gives a slope of 0.19 and an intercept of 36.39; the correlation 
coefficient = 0.96. (After Vidyashankar & Moudgal [44]). 
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hormone released from receptor binding is now available for binding to the 
antibody. This RIA system was subjected to extensive testing and validation 
(38,39) and was used to show that the beta subunit of LH is capable of 
binding to the cell and that this binding inhibits subsequent binding and 
response to intact LH (40). Essentially similar observations have been made 
by Dighe et al. (41) using hCG and its beta subunit and ovarian minces. The 
ability of the hCG beta subunit or its fragment o bind to the cellular recep- 
tor and evoke a response has been confirmed by others (42, 43). The modified 
RIA system has also been employed to determine the actual amount of FSH 
bound to various compartments of the ovary during the estrous cycle in the 
golden hamster (55). This study demonstrated that serum levels of FSH need 
not necessarily reflect the levels present in the tissue, the latter being a func- 
tion of the FSH receptor concentration i the ovary at a given time (Fig. 5). 
The high levels of FSH seen in the ovary on the evening of diestrous-2 
appears to be a reflection of receptor concentration and this occurs despite 
serum FSH being very low (Fig. 5). This assay has also been used to quanti- 
tate the FSH receptor concentration in the granulosa cells of immature 
estrogen primed rats (44). Vidyashankar and Moudgal (44) reported a value 
of 375 FSH binding sites/cell and a Kd of 3.03 • 10-1~ and these are similar 
to that obtained using 12sI FSH (45,46). The modified RIA system has also 
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Fig. 5. Pattern of ovarian and serum FSH levels throughout he 
estrous cycle of the hamster. FSH in the non-luteal ovarian tissue and 
in serum was determined by RIA carried out at 37~ The values are 
expressed in terms of NIAMDD rat FSH/RP standards. The dashed line 
represents the serum estradiol levels in the cycle hamster. (After Sheela 
Rani & Moudgal [551). 
Table 3. Demonstration of 'down regulation' of LH receptors using the RIA method 
Immature female rats made pseudopregnant by sequential treatment with PMSG and an 
ovulatory dose of hCG were treated with a desensitizing dose (4 gg) of hCG 4 d following 
the ovulatory trigger (t = 0 h). Control animals received saline. 48 h later the animals were 
treated with graded dose of hCG and killed at the 51st h, luteal tissue separated and hCG 
bound to it measured by the modified RIA. n of each group = 4. 
hOG (#g) treatment at 
Oh 48h 
Luteal tissue hCG 
(ng/10 mg tissue; mean + S.D.) 
- - O.05 -+ 0.11 
2 12.90 + 2.9 
- 4 19.40 -+ 2.4 
4 - 0.19 + 0.03 
4 1 1.72 + 0.66 
4 2 2.74 + 1.17 
4 4 2.47 + 0.6 
been used to  demonst ra te  'down regu la t ion '  o f  LH  receptors  (Tab le  3) as 
wel l  as re induct ion  o f  receptors  (30) .  In teres t ing ly  th is  s tudy  also showed 
that  the  down regu la t ion  o f  LH  receptors  is p robab ly  a pros tag land in  
med ia ted  event  s ince admin is t ra t ion  o f  indomethac in  pr io r  to  admin is t ra t ion  
o f  desens i t i z ing  doses  o f  hCG prevented  the  decrease  in the  LH receptors .  
Even  though the  R IA  method appears  labor ious  compared  to  the  s impl i s t i c  
use o f  12SI-labelled hormones ,  it p rov ides  each t ime a quant i ta t ion  o f  phys io -  
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logically active hormone bound to the receptor. Verification of basic 
concepts by this method is desirable as we are not sure if radioiodination, 
like any other chemical modification, alters the physiological state of the 
hormone. 
The response that follows binding of a gonadotropin to its receptor in 
most cases can be terminated by the addition of specific antisera in minute 
quantities to the incubation mixture. Thus in the case of the mouse Leydig 
cell, the cAMP production in response to LH could be blocked by addition 
of LH antiserum 15 min following exposure of cells to LH (47). In the case 
of FSH, using rat granulosa cells it has been shown that addition of FSH 
antiserum any time during a 4 h incubation period stops further synthesis of 
estrogen (44). Interestingly the ability of PMSG to induce FSH and LH 
receptors in granutosa cells of the female rat is also dependent upon the 
continuous presence of the hormonal stimulus (33), antiserum injection 
resulting in cessation of the inductive process. Using this model system it has 
been possible to calculate the half-life of the induced receptors, and this 
ranges between 7 and 8 h (33). 
In addition to affinity-labelling techniques, the common approach used in 
studying the structure-function relationship of hormones is by modifying 
the hormone chemically, and ascertaining how biological properties of the 
derivative have been altered. An alternative probe of considerable advantage 
in studying hormone receptor interaction is the use of specific antibody. 
Hormone receptors as well as hormone antibodies exhibit specific binding 
sites to the gonadotropin under test, but these binding sites need not neces- 
sarily be identical. Both polyclonal and monoclonal antibodies to the indi- 
vidual subunits have been used to obtain an insight into the hormonal 
domain(s) involved in receptor interaction. Our studies with the beta subunit 
of LH/hCG had revealed that this subunit has the minimal topography neces- 
sary for it to be recognized by the receptor. So it was envisaged that the first 
major interaction between the receptor and the hormone could perhaps be 
taking place largely through the beta subunit. If this were so, a large portion 
of the beta subunit of the native hormone would be expected to be buried 
inside the receptor socket while the alpha subunit would remain outside. The 
correctness of this hypothesis was verified by determining which of the two 
subunit antisera could inhibit the response to receptor bound hormone. The 
characterization f antisera raised to individual subunits for specificity was 
as outlined in an earlier section. Based on the ability of intact hCG and its 
subunits to displace 12sI hCG from binding to the subunit-specific antisera, it
was concluded that these antisera bound hCG through the respective subunit 
portion of the intact hormone molecule. The antisera used in the present 
study were equipotent with respect o their ability to bind hCG (Fig. 1). 
When the effect of these fintibodies on hCG stimulated testosterone produc- 
tion was studied, it was found that the hCG alpha antiserum was significantly 
more effective in blocking the response to hCG than hCG beta antiserum 
(Fig. 6). This effectiveness of the antiserum in blocking the response 
diminished as the time of association of the hormone with the cellular ecep- 
tor was prolonged, suggesting that antigenic determinants of receptor-bound 
hormone available for antibody binding diminish with time. The observation 
that hCG beta antiserum, even at the earliest ime point, was markedly tess 
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Fig. 6. Effect of addition of antisera on response to hCG as a function 
of the time of addition of antisera. Leydig cells were incubated with 
1000 pg hCG. 100 gl of 1:10 dilution of each antiserum was added to 
the flasks at various time points. Incubation was carried out at 34~ 
for 4 h. Testosterone s creted into the medium was estimated by RIA. 
Values are means-+ S.D. of triplicate flasks. Testosterone produced 
when no antiserum was added was 24.27 + 3.10 ng/flask/4 h. zx, hCG 
antiserum; e, hCG-alpha ntiserum; o, hCG-beta ntiserum. (After 
Dighe & Moudgal [191). 
effective in blocking response compared to hCG alpha antiserum suggests 
that (a) the initial recognition of  hCG by its receptor is achieved via binding 
sites located in the beta subunit leading to early disappearance of antibody 
binding sites in the beta portion of  the hCG molecule and (b) since the 
determinants of  the alpha subunit are available for antibody binding for a 
much longer time, the alpha subunit of  the hCG molecule should be oriented 
external to the beta. With time the orientation of the entire molecule could 
change, resulting in ineffectiveness of both the subunit antisera. Hwang and 
Menon (48), using a different approach of  cross linking hCG to the recep- 
tors, have confirmed that in hCG-receptor complex the beta subunit is 
buried between the receptor and the alpha subunit. Milius et al. (49), using 
subunit-specific antisera, have also concluded that the initial interaction 
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between hCG and the receptors takes place mainly through the beta subunit. 
According to them this interaction results in activation of the binding site 
in the receptor for the alpha subunit leading to a response. Moyle et al. (2l) 
have developed monoclonal antibodies against he alpha and the beta sub- 
units of hCG. They have reported five monoclonals, three of which (B 101, 
B102, and B103) were against he beta subunit while two (A101 and A102) 
were against he alpha subunit. It was concluded that two of the beta sub- 
unit antibodies (B102 and B103) recognized the epitopes that were not 
covered by the receptors, while one epitope (B 101) was in the receptor recog- 
nition domain of the hormone. Both the alpha subunit epitopes appear to 
be involved in binding to the receptor. The hCG beta antibodies we have 
obtained appear similar to B 101 of Moyle et al. (21) while our alpha antiserum 
is different from A101 and A102 in that it is able to bind receptor-bound 
hCG. 
In the receptor-gonadotropln-antibody interaction studies we have pri- 
marily conducted three types of experiments. Firstly it was demonstrated, for
both hCG/LH as well as for FSH, that a preformed hormone-antibody com- 
plex was unable to bind the receptor (both membrane and cells). The ability 
of the antibody to dissociate the gonadotropln that is already complexed to 
the receptor depended upon several factors like the species of gonadotropln, 
the time for which it has been associated with the receptor and finally the 
titer of the antibody used. Thus, in the case of rat LH, pregnant mare serum 
gonadotropin, or rat and ovine FSH, addition of antiserum at any time of 
hormone-receptor association caused dissociation of the hormone; in the 
case of cells exposed to hCG for 15 min or more it is virtually impossible to 
dissociate the complexed hormone with antibody (19,50,51). Ovine and 
equine LH appear to bind the receptor much less tightly compared to hCG 
(51). Interestingly, l~sI FSH bound to intact cellular eceptor is readily dis- 
sociable by antibody addition, compared to very tight binding seen when the 
labelled hormone is preincubated with membrane preparations (23). When 
the receptor preparation and antiserum are premixed before addition of 
12sI FSH, the ability of the antibody to prevent binding of radioiodinated 
hormone to the receptor depends on the antibody as well as its titer. Thus 
similar to that observed for hCG even in the case of FSH the antiserum to 
the beta subunit is significantly less effective in blocking binding of the 
hormone to the receptor than is the antiserum to intact FSH. 
Conclusion 
The versatility and usefulness of gonadotropin antibodies in studying the 
action of FSH and LH at the physiological, cellular and molecular level is 
described in the foregoing paper. Antibodies to LH and FSH, whether they 
be polyclonal or monoclonal in nature, need to be characterized for speci- 
ficity before being used as hormone antagonists. The cross-reactivity across 
species barrier which the gonadotropin antisera exhibit also makes it con- 
venient to use a single pool of characterized antiserum for neutralizing 
hormonal activity in different species. Considerable inputs into our know- 
ledge of basic aspects of reproductive endocrinology, like follicular matura- 
tion/atresia, ovulation, regulation of luteal function, maintenance of early 
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pregnancy and the need for FSH in regulating sperm production, have been 
made using this probe. More recently the LH and FSH antibodies have been 
used to investigate problems in hormone-receptor interaction and the 
response that follows as well as receptor induction and breakdown. An 
offshoot of the use of gonadotropin antibodies is the feasibility of using 
them as contraceptive accine for population control. 
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